|Mr. Douglas E. Godshall||CEO, Pres & Director||510.93k||N/A||1965|
|Mr. Daniel Puckett||CFO & Sec.||403.79k||N/A||1964|
|Mr. Isaac Zacharias||Chief Commercial Officer||349.42k||N/A||1975|
|Mr. Daniel Hawkins||Founder and Sr. Advisor||N/A||N/A||1967|
|Mr. John M. Adams||Co-Founder and Technical Advisor||N/A||N/A||1947|
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
ShockWave Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.